PHARNEXT
LIVE

Serial Number

88424864

Owner

PHARNEXT

Attorney

Carlynn Ferguson Davis

Filing Date

May 10, 2019

Add to watchlist:

No watchlists yet
View on USPTO

PHARNEXT Trademark

Serial Number: 88424864 • Registration: 6066907

PHARNEXT is a trademark filed by PHARNEXT on May 10, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PHARNEXT (19 trademarks)

46 rue Saint Lazare

Entity Type: 99

Trademark Details

Filing Date

May 10, 2019

Registration Date

June 2, 2020

Published for Opposition

March 17, 2020

Goods & Services

training services in the fields of health, pharmaceutical and medical research, pharmaceutical and medical development; publication of books and texts other than publicity texts in the pharmaceutical, medical and health fields; educational services, namely, arranging and conducting educational colloquiums, conferences, congresses, and seminars in the fields of pharmaceuticals, medical and health; teaching in the pharmaceutical, medical and health fields

Medicine, namely, medicines for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; pharmaceutical products for human use for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; pharmaceutical preparations for human or veterinary use for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; biological preparations for medical purposes for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; diagnostic preparations for medical diagnosis purposes; chemical preparations for medical purposes, namely, for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases, traumatic neuropathies and demyelinating neuropathies, autoimmune diseases, cancers, cardiovascular diseases, metabolic syndromes; food supplements and nutritional supplements for medical purposes; dietetic foods and beverages adapted for medical and pharmaceutical purposes; homeopathic and phyto-therapeutic supplements; disinfectants for hygiene purposes for medicine; bath preparations for medical purposes; dietetic beverages adapted for medical purposes; chemical reagents for medical use, namely, biomarkers; products for personal hygiene for medical purposes, namely, medical soaps; plasters and gauze for dressings for medical purposes; medical dressings, except instruments

Creation, compilation and management of databases and central data files in the field of pharmaceutical research and development, medicine, genetics and clinical trials; compilation of statistics in the field of health and medicine; collection and systematization of data in a central file in the field of pharmaceutical research and development, health and medicine; public relations in the field of health and medicine

medical services; pharmaceutical advice services; pharmacy consultation; medical advisory and information services relating to pharmaceutical products; medical information services; provision of medical information; providing health information services on the treatment of diseases through an awareness program

pharmaceutical products development; pharmaceutical research and development; conducting tests on pharmaceutical products; conducting clinical trials for pharmaceutical products for others; scientific research in the field of medicine; bioinformatics, chemical and biological analysis; scientific research in chemistry, cosmetology, biology, bacteriology, nutrition, biotechnology; biological research and bioinformatics services in the field of chemical, biological and pharmaceutical products; software development and design in the field of pharmaceutical research, health and medicine; provision of scientific information relating to pharmaceutical products and medical and scientific research in the field of pharmaceuticals products and clinical trials; scientific research on chemical reagents for medical use, namely, biomarkers; pharmaceutical research services

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 2, 2025 REM1
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jun 23, 2022 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 12, 2022 ASCK
REGISTERED-PRINCIPAL REGISTER
Jun 2, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 26, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 12, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 12, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 12, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 12, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 12, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 4, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 4, 2020 CRFA
ASSIGNED TO LIE
Feb 3, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 29, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 1, 2019 GNRN
NON-FINAL ACTION E-MAILED
Aug 1, 2019 GNRT
NON-FINAL ACTION WRITTEN
Aug 1, 2019 CNRT
ASSIGNED TO EXAMINER
Jul 25, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 25, 2019 NWOS
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
May 25, 2019 AMPX
ASSIGNED TO LIE
May 22, 2019 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
May 15, 2019 PARI
NEW APPLICATION ENTERED
May 14, 2019 NWAP